organophosphonates has been researched along with African Lymphoma in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Gräler, MH; Guntinas-Lichius, O; Jeya Paul, J; Thuy, AV; Weigel, C; Ziegler, AC | 1 |
Chen, Z; Lin, B; Liu, J; Qian, X; Xu, Y; Zhang, H | 1 |
Abdulkarim, B; Bourhis, J; Deutsch, E; Frascogna, V; Joab, I; Klijanienko, J; Sabri, S; Vainchenker, W; Zelenika, D | 1 |
Agbalika, F; Hocqueloux, L; Molina, JM; Oksenhendler, E | 1 |
4 other study(ies) available for organophosphonates and African Lymphoma
Article | Year |
---|---|
Validation of a monoclonal antibody directed against the human sphingosine 1-phosphate receptor type 1.
Topics: Anilides; Animals; Antibodies, Monoclonal; B-Lymphocytes; Burkitt Lymphoma; Endothelial Cells; Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; Immunoglobulin M; Mice; Organ Specificity; Organophosphonates; Palatine Tonsil; Sphingosine-1-Phosphate Receptors; T-Lymphocytes | 2021 |
7-b, a novel amonafide analogue, cause growth inhibition and apoptosis in Raji cells via a ROS-mediated mitochondrial pathway.
Topics: Adenine; Antineoplastic Agents; Apoptosis; Burkitt Lymphoma; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Drug Evaluation, Preclinical; Humans; Mitochondria; Models, Biological; Naphthalimides; Necrosis; Organophosphonates; Reactive Oxygen Species; Signal Transduction | 2011 |
Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies.
Topics: Animals; Antiviral Agents; Apoptosis; bcl-2-Associated X Protein; Burkitt Lymphoma; Carcinoma; Caspase 3; Caspase 9; Caspases; Cell Division; Cidofovir; Combined Modality Therapy; Cytosine; Enzyme Activation; Epstein-Barr Virus Infections; Female; Gene Expression Regulation, Viral; Genes, bcl-2; Herpesvirus 4, Human; Humans; Mice; Mice, Nude; Nasopharyngeal Neoplasms; Oncogene Proteins, Viral; Organophosphonates; Organophosphorus Compounds; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Radiation Tolerance; Remission Induction; Tumor Cells, Cultured; Tumor Stem Cell Assay; Tumor Virus Infections; Viral Matrix Proteins; Xenograft Model Antitumor Assays | 2003 |
Long-term remission of an AIDS-related primary effusion lymphoma with antiviral therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antineoplastic Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; Burkitt Lymphoma; Cidofovir; Cytosine; Herpesvirus 4, Human; Herpesvirus 8, Human; HIV Long-Term Survivors; HIV Protease Inhibitors; Humans; Interferon-alpha; Lymphoma, B-Cell; Male; Organophosphonates; Organophosphorus Compounds; Pleural Effusion; Sarcoma, Kaposi; Time Factors | 2001 |